Arcadia Biosciences, Inc.
RKDANext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for RKDA. That does not mean none is planned.
Get an email about RKDA's next catalysts
Track Arcadia Biosciences (RKDA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 2 past
No catalysts found.
Market Overview
Stock performance and key metrics
Arcadia Biosciences (Nasdaq: RKDA) is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
WebsiteNo drugs found in this phase.
Frequently asked questions
When is Arcadia Biosciences, Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Arcadia Biosciences, Inc. (RKDA) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track RKDA biotech catalysts?β
Add RKDA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Arcadia Biosciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
